AMLX
Price
$31.62
Change
-$0.47 (-1.46%)
Updated
Sep 11 closing price
Capitalization
3.52B
54 days until earnings call
Intraday BUY SELL Signals
LEGN
Price
$18.64
Change
-$0.55 (-2.87%)
Updated
Sep 11 closing price
Capitalization
3.62B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs LEGN

AMLX vs LEGN Comparison Chart in %
View a ticker or compare two or three
VS
AMLX vs. LEGN commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and LEGN is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($3.62B) and AMLX($3.52B) have the same market capitalization . AMLX YTD gains are higher at: 161.755 vs. LEGN (-14.259). LEGN has higher annual earnings (EBITDA): 11.5M vs. AMLX (-161.73M). LEGN has more cash in the bank: 965M vs. AMLX (251M). AMLX has less debt than LEGN: AMLX (5.26M) vs LEGN (278M). LEGN has higher revenues than AMLX: LEGN (1.27B) vs AMLX (0).
AMLXLEGNAMLX / LEGN
Capitalization3.52B3.62B97%
EBITDA-161.73M11.5M-1,406%
Gain YTD161.755-14.259-1,134%
P/E Ratio2.69N/A-
Revenue01.27B-
Total Cash251M965M26%
Total Debt5.26M278M2%
FUNDAMENTALS RATINGS
LEGN: Fundamental Ratings
LEGN
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXLEGN
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (AMLX: $31.62 vs. LEGN: $18.64)
Brand notoriety: AMLX and LEGN are both not notable
AMLX represents the Pharmaceuticals: Generic, while LEGN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 78% vs. LEGN: 78%
Market capitalization -- AMLX: $3.52B vs. LEGN: $3.62B
AMLX [@Pharmaceuticals: Generic] is valued at $3.52B. LEGN’s [@Biotechnology] market capitalization is $3.62B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $63.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green while LEGN’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • LEGN’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than LEGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while LEGN’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 5 bearish.
  • LEGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LEGN is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а -7.27% price change this week, while LEGN (@Biotechnology) price change was -13.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -5.31%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +30.17%.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 05, 2026.

LEGN is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-5.31% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AMLX
Daily Signal:
Gain/Loss:
LEGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EFAV93.980.72
+0.77%
iShares MSCI EAFE Min Vol Factor ETF
AHLT30.430.21
+0.69%
American Beacon AHL Trend ETF
FTNY7.530.03
+0.40%
Franklin New York Municipal Income ETF
BAMY26.990.01
+0.04%
Brookstone Yield ETF
MBBB20.62-0.01
-0.03%
VanEck Mdy's Aly BBB Corp Bd ETF

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with OCUL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-1.46%
OCUL - AMLX
46%
Loosely correlated
-1.22%
LRMR - AMLX
45%
Loosely correlated
+1.82%
JAZZ - AMLX
43%
Loosely correlated
+2.21%
RGNX - AMLX
43%
Loosely correlated
-0.35%
IDYA - AMLX
43%
Loosely correlated
+0.37%
More

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
-2.87%
AXON - LEGN
37%
Loosely correlated
+0.10%
AMLX - LEGN
35%
Loosely correlated
-1.46%
WVE - LEGN
31%
Poorly correlated
-1.71%
AMRN - LEGN
31%
Poorly correlated
-1.71%
ARRY - LEGN
30%
Poorly correlated
+1.54%
More